Dr. De Wilde Fernand

Active

Private limited companyfounded 2023active for 2 yearsKortrijksesteenweg 206, 9830 Sint-Martens-Latem, BelgiumKBO/BCE: BE 1004.052.740

From the official registers: KBO 2 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. De Wilde Fernand has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €971,411 and a net result of €364,008. Its solvency ranks better than 40% of 3,023 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Dr. De Wilde FernandActiveChecked score 92/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 18-12-2023 Normal situation
Legal form: Private limited company
Registered office: Kortrijksesteenweg 206, 9830 Sint-Martens-Latem
Activity: Specialist medical practice NACE 86220
Establishment units: 4 establishment units
Financial year end: 31 December
Peppol: Reachable since 27-03-2025

Company details

Who decides

Board

Eqiris NVDirector · since 04-01-2024 · permanent representative Maria Dieltiëns
Signifeye NVDirector · since 04-01-2024 · permanent representative Kathleen Moons
DE WILDE Fernand André MarieDirector · since 18-12-2023

Shareholders

EQIRIS100%annual accounts 2025

Board & ownership

How it is doing

92 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €1.3m; ▼ 44.9%
Turnover: ≈ €1.1m; estimated
Profit: €364,008; ▼ 61.0%
Equity: €971,411; ▲ 0.4%
Total assets: €2.0m; ▼ 11.7%
Staff: 9 FTE; ▲ 73.1%

2025 accounts 31 days early

Filed on 30-06-2026at the National Bank

Financials

Why 92lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.35, cash €409,910Figures for financial year 2025 (filed 30-06-2026)Equity €971,411 (47.8% of total assets)Show the evidence

Checked score

Score 2025

92 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 36% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 73+6

equity 47.8% of total assets

Liquidity 49-8

short-term debt 51.3% · cash 20.2%

Profitability 91-9

return on assets 17.9%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 01-2025: 0.4% 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.4 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: < 0.1%▼ -0.2 percentage points vs 09-2026

Credit of up to €85,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record

Liquidity tight (current ratio 1.35, compared with 1.3 in 2024, below the usual 1.5; short-term debt: 51.3% and cash: 20.2% of total assets), and 52.2% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 38% on solvency, 17% on liquidity, 47% on profitability and 39% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 1.35, cash €409,910

NBB · annual accounts

Figures for financial year 2025 (filed 30-06-2026)

NBB · annual accounts

Equity €971,411 (47.8% of total assets)

NBB · annual accounts

Young company

Founded in 2023, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.

KBO · incorporation date

Age against the risk zone

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.

NBB · 2 filings

Deviation from the deadline

2025

31 days early

2024

6 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 19 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Where today falls in the filing period

31-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since incorporation in 2023.

KBO publications · our coverage

Key points

Caution: Result fell in 2025from €934,142 to €364,008 ▼ 61.0% View
Positive: 9th largest company by total assets in Sint-Martens-Latem, Health and social work…in the Checked rankings No. 9 View
Controlled by EQIRISultimately: Signifeye 100% View

Documents

Key facts about Dr. De Wilde Fernand

What is the company number of Dr. De Wilde Fernand?: 1004.052.740. In Belgium the VAT number is the company number with BE in front: BE 1004.052.740.
Where is Dr. De Wilde Fernand based?: The registered office is at Kortrijksesteenweg 206, 9830 Sint-Martens-Latem.Company details
What does Dr. De Wilde Fernand do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. De Wilde Fernand?: Private limited company (BV).
When was Dr. De Wilde Fernand founded?: On 18-12-2023.
Is Dr. De Wilde Fernand still active?: Yes, Dr. De Wilde Fernand is an active enterprise in the KBO register.
How many employees does Dr. De Wilde Fernand have?: On average 9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Dr. De Wilde Fernand?: ≈ €1.1m in financial year 2025. Estimated from the gross margin of €1.3m: probably between €1.0m and €1.7m, based on 64 comparable companies, NACE 86.
Is Dr. De Wilde Fernand profitable?: In financial year 2025, Dr. De Wilde Fernand made a profit of €364,008.
Where can I find the annual accounts of Dr. De Wilde Fernand?: Dr. De Wilde Fernand filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. De Wilde Fernand due?: By 31-07-2027, for financial year 2026.Timeline